What are Bioventus's total assets?

Bioventus (BVS) holds $650.5M in total assets, down 5.9% year over year.

How much debt does Bioventus have?

Bioventus carries $288.4M in total debt against $188.9M of shareholders' equity, a debt-to-equity ratio of 1.53.

How much cash does Bioventus have?

Bioventus holds $35.8M in cash and equivalents.

Can Bioventus cover its short-term obligations?

Its current ratio is 1.69 — current assets exceed current liabilities.

Where does Bioventus's balance sheet data come from?

Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bioventus BVS Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$35.85M+57.2%	$51.24M+23.2%	$42.16M-2.1%	$32.91M+2.9%	$22.8M-9.4%
Accounts receivable, net	$523.32M+1.4%	$520.65M-0.6%	$519.7M-0.2%	$511.18M-0.5%	$516.12M+3.1%
Inventories	$358.16M-1.6%	$369.02M+0.5%	$379.26M+3.6%	$373.02M-1.2%	$364.16M-6.3%
Raw materials	$19.3M-15.5%	$21.24M-3.9%	$21.91M-6.6%	$23.44M-5.6%	$22.84M-11.1%
Finished goods	$63.89M-10.3%	$61M-13.3%	$74.37M+11.7%	$73.03M+16.3%	$71.2M-0.2%
Prepaid expenses and other current assets	$10.26M-29.0%	$11.07M-21.9%	$12.06M-28.7%	$13.46M-42.9%	$14.44M-20.6%
Total current assets	$249.81M+0.2%	$272.84M-1.0%	$280.9M-6.0%	$275.2M-10.9%	$249.37M-6.2%
Property and equipment, net	$21.29M-17.2%	$21.9M-18.9%	$22.98M-21.9%	$24.51M-23.3%	$25.72M-25.5%
Operating lease right-of-use assets	5.2%0.0%	5.2%-650,599,995%	5.2%+0.3%	5.2%+0.4%	5.2%+0.5%
Goodwill	$7.46M0.0%	$7.46M0.0%	$7.46M0.0%	$7.46M0.0%	$7.46M0.0%
Intangible assets, net	$359.66M-9.1%	$368.42M-9.0%	$377.4M-9.0%	$386.95M-8.9%	$395.73M-15.9%
Equity method investments	$2.1M+19.7%	$2.29M+21.2%	$2.27M+17.6%	$1.69M-19.2%	$1.76M-45.3%
Total assets	$650.54M-5.9%	$683.56M-6.1%	$701.59M-8.8%	$706.79M-10.8%	$691.41M-12.9%
Accounts payable	$24.05M+25.3%	$10.93M-53.9%	$26.65M+58.2%	$24.25M-0.8%	$19.2M+0.5%
Accrued expenses	$4.16M-4.6%	$4.21M+7.5%	$4.41M+12.5%	$4.41M+15.2%	$4.36M-9.3%
Current portion of long-term debt	$18.75M-49.8%	$15M-45.1%	$11.25M-70.8%	$43.36M+12.4%	$37.34M+4.3%
Operating lease liabilities, current	$3.23M-8.3%	$3.3M+6.5%	$3.53M+13.3%	$3.55M+16.9%	$3.52M-12.6%
Finance Lease Liability, Current	$933K+11.1%	$907K+11.3%	$881K+9.4%	$860K+8.7%	$840K+8.0%
Income taxes payable	$4.81M-21.6%	$5.14M+32.8%	$4.83M-21.4%	$4.64M-4.9%	$6.14M+22.3%
Accrued interest	$2.85M-37.8%	$3.17M-40.5%	$3.53M-40.5%	$4.43M-28.4%	$4.58M-29.0%
Total current liabilities	$148.1M-15.3%	$160.38M-23.8%	$161.75M-23.5%	$185.68M-19.8%	$174.75M+0.8%
Long-term debt	$253.33M-17.9%	$278.95M-9.5%	$311.33M-9.8%	$297.88M-13.6%	$308.59M-13.2%
Operating lease liabilities, non-current	$3.7M-42.4%	$4.46M-35.8%	$5.21M-33.1%	$5.82M-31.2%	$6.43M-33.6%
Finance Lease Liabilities (Total)	$9.41M-8.2%	$9.64M-7.2%	$9.84M-7.0%	$10.05M-6.7%	$10.25M-6.5%
Operating Lease Liabilities (Total)	$6.93M-30.3%	$7.76M-22.7%	$8.74M-19.8%	$9.37M-18.5%	$9.95M-27.4%
Finance lease liabilities	$8.48M-9.9%	$8.73M-8.8%	$8.96M-8.3%	$9.19M-8.0%	$9.41M-7.6%
Other non-current liabilities	$14.29M-35.0%	$15.35M-33.6%	$20.47M-21.7%	$21.28M-21.0%	$21.98M-22.4%
Total liabilities	$416.27M-17.7%	$455.11M-16.1%	$494.34M-15.2%	$505.49M-16.2%	$505.94M-12.3%
Additional paid-in capital	$522.91M+2.4%	$520.85M+2.5%	$517.53M+2.9%	$514.77M+2.8%	$510.42M+2.7%
Retained earnings	-$331.82M+7.9%	-$334.93M+6.4%	-$349.68M+1.5%	-$352.84M-0.8%	-$360.3M-10.5%
Accumulated other comprehensive income (loss)	-$2.28M-10.5%	-$1.9M+26.2%	-$1.84M-513%	-$774K-4,453%	-$2.06M-734%
Noncontrolling interests	$45.36M+21.5%	$44.34M+17.7%	$41.16M+8.0%	$40.06M+5.1%	$37.34M-19.1%
Total stockholders' equity	$188.9M+27.5%	$184.11M+24.4%	$166.1M+11.7%	$161.24M+6.8%	$148.14M-13.5%
Total liabilities and stockholders' equity	$650.54M-5.9%	$683.56M-6.1%	$701.59M-8.8%	$706.79M-10.8%	$691.41M-12.9%
Allowance for Doubtful Accounts	$3.06M+8.0%	$2.9M+1.4%	$2.86M+1.5%	$2.9M0.0%	$2.83M-9.5%
Allowance for Doubtful Accounts Receivable (Current)	$3.06M+8.0%	$2.9M+1.4%	$2.86M+1.5%	$2.9M0.0%	$2.83M-9.5%
Raw materials and supplies inventory, gross	$19.3M-15.5%	$21.24M-3.9%	$21.91M-6.6%	$23.44M-5.6%	$22.84M-11.1%
Net Investment in Lease	$4.69M-29.3%	$5.12M-21.3%	$5.83M-40.4%	$6.23M-39.9%	$6.63M-46.8%
Deferred tax assets	$5.52M+16.4%	$5.52M—	$4.75M—	$4.75M—	$4.75M—
Deferred tax assets	——	——	——	——	——
Other intangible assets—net	$359.66M-9.1%	$368.42M-9.0%	$377.4M-9.0%	$386.95M-8.9%	$395.73M-15.9%
Investments	$2.1M+19.7%	$2.29M+21.2%	$2.27M+17.6%	$1.69M-19.2%	$1.76M-45.3%
Operating lease right-of-use assets	$4.69M-29.3%	$5.12M-21.3%	$5.83M-40.4%	$6.23M-39.9%	$6.63M-46.8%
Property, plant and equipment, net	$21.29M-17.2%	$21.9M-18.9%	$22.98M-21.9%	$24.51M-23.3%	$25.72M-25.5%
Operating Lease Right-of-Use Assets in Other Assets	$4.69M-29.3%	$5.12M-21.3%	$5.83M-40.4%	$6.23M-39.9%	$6.63M-46.8%
Other Commercial Liabilities	$101.14M-2.1%	$130.24M-4.1%	$119.45M-7.2%	$113.67M-18.8%	$103.28M-9.1%
Accrued Liabilities, Current	$101.14M-2.1%	$130.24M-4.1%	$119.45M-7.2%	$113.67M-18.8%	$103.28M-9.1%
Other accrued liabilities	$4.16M-4.6%	$4.21M+7.5%	$4.41M+12.5%	$4.41M+15.2%	$4.36M-9.3%
Debt Maturity - 2025	——	——	——	——	——
Debt Maturity - 2026	——	——	——	——	——
Debt Maturity - 2027	——	——	——	——	——
Debt Maturity - 2028	——	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$539K-45.6%	$570K-50.3%	$591K-54.6%	$834K-42.8%	$990K-38.7%
Total debt	$288.42M-21.2%	$311.35M-12.6%	$341.17M-15.8%	$360.66M-11.1%	$366.13M-12.0%
Common Stock Shares Outstanding	$11.84M-6.6%	$7.78M-54.4%	$5.93M—	$6.44M—	$12.68M—
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Number of Exercisable Options	——	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	5.7M+12.0%	4.7M+0.8%	4.7M-4.9%	4.8M-6.8%	5.1M-8.9%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——	——
Weighted Average Exercise Price of Exercisable Options	——	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	$7.93+0.5%	$7.77+0.5%	$7.79+2.8%	$7.73+2.7%	$7.89+3.7%
Number of Interest Rate Derivatives Held	——	——	——	——	——
Accrued bonuses	$12.45M+5.4%	$25.04M-23.3%	$18.6M-26.9%	$15.78M-21.0%	$11.82M-14.8%
Compensation and benefits	$6.19M+5.9%	$6.56M-13.7%	$6.67M-10.1%	$6.96M-23.4%	$5.85M-7.7%
Allowance for doubtful accounts	$3.06M+8.0%	$2.9M+1.4%	$2.86M+1.5%	$2.9M0.0%	$2.83M-9.5%
Less: net unamortized discount	$1.64M+73.6%	$1.73M+58.6%	$1.83M+47.4%	$792K-42.9%	$942K-38.6%
Deferred income taxes	$568K-6.4%	$433K-23.2%	$786K—	$651K—	$607K-53.1%
Cost not yet recognized	——	——	——	——	——
Current maturities of long-term debt	$933K+11.1%	$907K+11.3%	$881K+9.4%	$860K+8.7%	$840K+8.0%
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$10.84M-12.5%	$11.22M-11.7%	$11.61M-11.4%	$11.99M-11.1%	$12.38M-10.8%
Gross-to-net deductions	$58.91M-3.8%	$73.49M+10.7%	$71.15M+4.2%	$66.93M-2.1%	$61.2M-4.2%
Line of credit facility, number of LOCs outstanding	30.0%	3—	3—	3—	3—
2028	——	——	——	——	——
2030	——	——	——	——	——
2030 - Final payment at Maturity	——	——	——	——	——
2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
2030 - Final payment at Maturity	——	——	——	——	——
Noncontrolling interests in subsidiaries	$45.36M+21.5%	$44.34M+17.7%	$41.16M+8.0%	$40.06M+5.1%	$37.34M-19.1%
Operating Lease Weighted Average Discount Rate Percent	$0.050.0%	$0.05+2.0%	$0.05+6.1%	$0.05+8.3%	$0.05+10.6%
Other accrued liabilities	$15.93M+16.3%	$16.85M-15.9%	$14.68M-5.1%	$14.93M+8.5%	$13.7M-24.0%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$5.67M+12.0%	$4.66M+0.8%	$4.68M-4.9%	$4.78M-6.8%	$5.06M-8.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$7.93+0.5%	$7.77+0.5%	$7.79+2.8%	$7.73+2.7%	$7.89+3.7%
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$11.84M-6.6%	$7.78M-54.4%	$5.93M—	$6.44M—	$12.68M—
Tax receivable agreement, percent	——	——	——	——	——
Weighted-Average Discount Rate	8.1%0.0%	8.1%0.0%	8.1%0.0%	8.1%0.0%	8.1%0.0%
Weighted-Average Discount Rate - Finance Leases	$0.080.0%	$0.080.0%	$0.080.0%	$0.080.0%	$0.080.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bioventus.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Bioventus's total assets?: Bioventus (BVS) holds $650.5M in total assets, down 5.9% year over year.
How much debt does Bioventus have?: Bioventus carries $288.4M in total debt against $188.9M of shareholders' equity, a debt-to-equity ratio of 1.53.
How much cash does Bioventus have?: Bioventus holds $35.8M in cash and equivalents.
Can Bioventus cover its short-term obligations?: Its current ratio is 1.69 — current assets exceed current liabilities.
Where does Bioventus's balance sheet data come from?: Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.